HTGM
HTG Molecular Diagnostics Inc
-37.26%
$4.67 - $2.93
Feb 7th 2023 - Mar 21st 2023
Jan, 13, 2023
$HTGM is over 100% since yesterday, looks for a go... See more
Dec, 27, 2022
Plus it is expecting more positive catalysts in we... See more
AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Feb, 4, 2023
This is getting the accelerated approval chances a... See more
Jan, 28, 2023
$AVXL Kun Jin hire is the best indication we'r... See more
PALI
Palisade Bio Inc
-19.56%
$2.25 - $1.81
Feb 7th 2023 - Mar 21st 2023
Jan, 5, 2023
Same exact ind approval news as maybe we see a re... See more
Oct, 6, 2022
Potential 100% or more upside due to soonest low f... See more
Jan, 13, 2023
$HTGM is over 100% since yesterday, looks for a good entry $KERN had a lot of volume yesterday $1.5 can be a good entry $VYNE announce split has been approved by board and can be executed at any time
Dec, 27, 2022
Plus it is expecting more positive catalysts in weeks and months: 5 year data for breast cancer, Canada approval, China commercialziation, and much more.
Dec, 14, 2022
FDA approved.
Feb, 4, 2023
This is getting the accelerated approval chances as clost to 100% as you humanly can.
Jan, 28, 2023
$AVXL Kun Jin hire is the best indication we're going full bore for alz approval ASAP.
Jan, 24, 2023
He said Anavex could do that also and all of that makes Anavex pleased how easy the FDA wants to make Accelerated approval here.
Jan, 13, 2023
Anavex can still rise .. Blarcamesine will likely get approval around the world ๐
Jan, 12, 2023
So the current price level is so cheap and has so little downside that even with concerns about data and approval, the stock can rise 5x from here.
Jan, 6, 2023
That's all perfect it's everything needed for full approval!
Jan, 6, 2023
Well it was bound for an approval because the bar is low and aggregate economic benefit would far outweigh the aggregate economic burden from funerals cost Bullish for $AVXL $BIVI
Jan, 6, 2023
look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
Jan, 6, 2023
I think this bodes well for A2-73 getting AA and approval, being it is much safer and with better efficacy, it appears AA is coming to A2-73,
Jan, 5, 2023
Same exact ind approval news as maybe we see a repeat here even 100% run would be awesome.
Oct, 6, 2022
Potential 100% or more upside due to soonest low float thanks to reverse stock split approved last 04 october 2022 and massive short from hedge fund thinking to obtain 110 mil cashless warrants!